Hemlibra

Hemlibra Description

emicizumab

Manufacturer:

Roche

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
Hemlibra 30 mg/mL solution for injection: Each mL of solution contains 30 mg of emicizumab*.
Each vial of 1 mL contains 30 mg of emicizumab at a concentration of 30 mg/mL.
Hemlibra 150 mg/mL solution for injection: Each mL of solution contains 150 mg of emicizumab*.
Each vial of 0.4 mL contains 60 mg of emicizumab at a concentration of 150 mg/mL.
Each vial of 0.7 mL contains 105 mg of emicizumab at a concentration of 150 mg/mL.
Each vial of 1 mL contains 150 mg of emicizumab at a concentration of 150 mg/mL.
*Emicizumab is a humanised monoclonal modified immunoglobulin G4 (IgG4) antibody produced using recombinant DNA technology in mammalian Chinese Hamster Ovary (CHO) cells.
Excipients/Inactive Ingredients: L-Arginine, L-Histidine, L-Aspartic acid, Poloxamer 188, Water for injections.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in